0000899243-16-023480.txt : 20160623 0000899243-16-023480.hdr.sgml : 20160623 20160623160741 ACCESSION NUMBER: 0000899243-16-023480 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160621 FILED AS OF DATE: 20160623 DATE AS OF CHANGE: 20160623 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: KERYX BIOPHARMACEUTICALS INC CENTRAL INDEX KEY: 0001114220 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 134087132 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 750 LEXINGTON AVENUE STREET 2: . CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-531-5965 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Morrison Jodie Pope CENTRAL INDEX KEY: 0001618247 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30929 FILM NUMBER: 161728723 MAIL ADDRESS: STREET 1: C/O TOKAI PHARMACEUTICALS, INC. STREET 2: ONE BROADWAY, 14TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-06-21 0 0001114220 KERYX BIOPHARMACEUTICALS INC KERX 0001618247 Morrison Jodie Pope C/O KERYX BIOPHARMACEUTICALS, INC. ONE MARINA PARK DRIVE, 12TH FLOOR BOSTON MA 02210 1 0 0 0 Stock Options (right to buy) 6.05 2016-06-21 4 A 0 50000 0.00 A 2017-06-21 2026-06-21 Common Stock 50000 50000 D The 50,000 stock options vest as follows: 16,667 on June 21, 2017; 16,667 on June 21, 2018; 16,666 on June 21, 2019. /s/ Brian Adams, Attorney-in-Fact 2016-06-23